摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-methyl-5-(pyridazin-4-yl)-4H-1,2,4-triazole-3-thiol

中文名称
——
中文别名
——
英文名称
4-methyl-5-(pyridazin-4-yl)-4H-1,2,4-triazole-3-thiol
英文别名
4-methyl-3-pyridazin-4-yl-1H-1,2,4-triazole-5-thione
4-methyl-5-(pyridazin-4-yl)-4H-1,2,4-triazole-3-thiol化学式
CAS
——
化学式
C7H7N5S
mdl
——
分子量
193.232
InChiKey
VWRZVBBBJDQJAZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.4
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    85.5
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] DOPAMINE D3 RECEPTOR ANTAGONISTS HAVING A BICYCLO MOIETY<br/>[FR] ANTAGONISTES DU RÉCEPTEUR D3 DE LA DOPAMINE AYANT UN FRAGMENT BICYCLO
    申请人:INDIVIOR UK LTD
    公开号:WO2017021920A1
    公开(公告)日:2017-02-09
    The disclosure provides compounds having formula (I), wherein the substituents are as defined herein. The compounds are useful for modulating the dopamine D3 receptor and for treating conditions associated therewith, such as addictions, drug dependency, and psychiatric conditions.
    该披露提供了具有化学式(I)的化合物,其中取代基如本文所定义。这些化合物可用于调节多巴胺D3受体,并用于治疗与之相关的疾病,如成瘾、药物依赖和精神疾病。
  • 1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists
    作者:Fabrizio Micheli、Andrea Bernardelli、Federica Bianchi、Simone Braggio、Laura Castelletti、Palmina Cavallini、Paolo Cavanni、Susanna Cremonesi、Michele Dal Cin、Aldo Feriani、Beatrice Oliosi、Teresa Semeraro、Luca Tarsi、Silvia Tomelleri、Andrea Wong、Filippo Visentini、Laura Zonzini、Christian Heidbreder
    DOI:10.1016/j.bmc.2016.02.031
    日期:2016.4
    high affinity and selectivity at the DA D3 receptor is reported here. Compounds endowed with high selectivity over the hERG channel were identified and their pharmacokinetic properties thoroughly analyzed. A few derivatives with appropriate developability characteristics were selected for further studies and progression along the screening cascade. In particular, derivative 60a, (DA D3 pKi = 8.4, DA D2
    本文报道了一系列新的1,2,4-三唑基八氢吡咯并[2,3- b ]吡咯在DA D3受体上表现出高亲和力和选择性。鉴定了在hERG通道上具有高选择性的化合物,并对其药代动力学特性进行了全面分析。选择了一些具有适当可显影性的衍生物,以进一步研究并沿着筛选级联进行。特别地,衍生物60a(DA D3 p K i  = 8.4,DA D2 p K i  = 6.0和hERG fp K i  = 5.2)显示出平衡的分布,并且围绕该分子进行进一步的改进。
  • Exploration of the Amine Terminus in a Novel Series of 1,2,4-Triazolo-3-yl-azabicyclo[3.1.0]hexanes as Selective Dopamine D<sub>3</sub> Receptor Antagonists
    作者:Fabrizio Micheli、Luca Arista、Barbara Bertani、Simone Braggio、Anna Maria Capelli、Susanna Cremonesi、Romano Di-Fabio、Giacomo Gelardi、Gabriella Gentile、Carla Marchioro、Alessandra Pasquarello、Stefano Provera、Giovanna Tedesco、Luca Tarsi、Silvia Terreni、Angela Worby、Christian Heidbreder
    DOI:10.1021/jm100832d
    日期:2010.10.14
    novel series of 1,2,4-triazol-3-yl-azabicyclo[3.1.0]hexanes with high affinity and selectivity for the DA D3 receptor and excellent pharmacokinetic profiles was recently reported. We also recently discussed the role of the linker associated with the triazole moiety. In this manuscript, we are reporting a detailed exploration of the region of the receptor interacting with the amine terminus of the scaffold
    最近报道了一系列新的1,2,4-三唑-3-基-氮杂双环[3.1.0]己烷,对DA D 3受体具有高亲和力和选择性,并具有出色的药代动力学特征。我们最近还讨论了与三唑部分相关的接头的作用。在此手稿中,我们报告了与支架的胺末端相互作用的受体区域的详细探索,其中进行了与这些新型模板相关的SAR和可开发性数据。
  • 1,2,4-Triazolyl 5-Azaspiro[2.4]heptanes: Lead Identification and Early Lead Optimization of a New Series of Potent and Selective Dopamine D3 Receptor Antagonists
    作者:Fabrizio Micheli、Alessia Bacchi、Simone Braggio、Laura Castelletti、Palmina Cavallini、Paolo Cavanni、Susanna Cremonesi、Michele Dal Cin、Aldo Feriani、Sylvie Gehanne、Mahmud Kajbaf、Luciano Marchió、Selena Nola、Beatrice Oliosi、Annalisa Pellacani、Elisabetta Perdonà、Anna Sava、Teresa Semeraro、Luca Tarsi、Silvia Tomelleri、Andrea Wong、Filippo Visentini、Laura Zonzini、Christian Heidbreder
    DOI:10.1021/acs.jmedchem.6b00972
    日期:2016.9.22
    A novel series of 1,2,4-triazolyl 5-azaspiro[2.4]heptanes with high affinity and selectivity at the dopamine (DA) D3 receptor (D3R) is described. Some of these compounds also have high selectivity over the hERG channel and were characterized with respect to their pharmacokinetic properties both in vitro and in vivo during lead identification and early lead optimization phases. A few derivatives with
    描述了一个新的1,2,4-三唑基5-氮杂螺[2.4]庚烷系列,对多巴胺(DA)D3受体(D3R)具有高亲和力和选择性。这些化合物中的一些在hERG通道上也具有很高的选择性,并且在铅鉴定和早期铅优化阶段的体内和体外药代动力学特性方面进行了表征。选择了一些具有总体良好的可开发性特征的衍生物用于进一步的后期铅优化研究。
  • PROCESS FOR PREPARING HETEROCYCLIC DERIVATIVES
    申请人:Bacchi Sergio
    公开号:US20070232808A1
    公开(公告)日:2007-10-04
    The present invention relates to a novel process, useful for preparing key intermediates of formula (I) in the synthesis of various compounds, among them compounds which are potent and specific antagonists of D3 receptors, in which X may be Nitrogen or Sulfur; Het means aryl or heteroaryl; each of which may be substituted by 1 to 4 groups J selected from: halogen, C1-C6 alkyl C1-C6 alkoxy, halo C1-C6 alkyl C2-C6 alkenyl, C2-C6 alkynyl, halo C1-C6 alkoxy, —C(O)R 1 , nitro, hydroxy, —NR 2 R 3 , cyano or a group Z; R 1 is a C1-C4 alkyl —OR 3 or —NR 3 R 4 ; R 2 is hydrogen or C1-C6 alkyl; R 3 is hydrogen or C1-C6 alkyl; R is H, C1-C6 alkyl aryl, benzyl; each of which may be substituted by 1 to 4 groups J; according to the following Scheme 1: in which step a means a reaction in basic conditions of compounds (IIA) with 3-thiosemicarbazide derivatives, followed by a treatment with an inorganic base and n-propane phosphonic cyclic anhydride and final pH adjustment with inorganic acids to give compounds of formula (II).
    该发明涉及一种新型工艺,用于制备公式(I)中的关键中间体,在合成各种化合物中起作用,其中这些化合物是D3受体的有效和特异性拮抗剂, 其中 X 可以是氮或硫; Het 表示芳基或杂环芳基;每个可以被1至4个J基团取代,所述J基团选自: 卤素,C1-C6烷基,C1-C6烷氧基,卤代C1-C6烷基,C2-C6烯基,C2-C6炔基,卤代C1-C6烷氧基,—C(O)R 1 ,硝基,羟基,—NR 2 R 3 ,氰基或Z基团; R 1 是C1-C4烷基,—OR 3 或—NR 3 R 4 ; R 2 是氢或C1-C6烷基; R 3 是氢或C1-C6烷基; R 是H,C1-C6烷基芳基,苄基;每个可以被1至4个J基团取代; 根据以下Scheme 1: 其中 步骤a表示化合物(IIA)在碱性条件下与3-硫代脲衍生物发生反应,然后经过与无机碱和正丙磷酸环状酐的处理,并最终通过无机酸进行pH调节,得到公式(II)的化合物。
查看更多